2026 advances in feline hyperthyroidism management include improved biomarker testing, refined treatment protocols, and better understanding of concurrent disease interactions affecting welfare outcomes.
2026 advances in hyperthyroidism management have improved the welfare of affected cats through faster diagnosis, more refined treatment protocols, and better tools for monitoring treatment response. Cats benefit from earlier diagnosis when point-of-care testing is used at routine wellness visits, enabling intervention before significant cardiovascular or renal complications develop.